SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia - Concepedia

Concepedia

Publication | Closed Access

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

53

Citations

24

References

2014

Year

Éric Pasmant, Brigitte Gilbert‐Dussardier, Arnaud Petit, Bérengère de Laval, Armelle Luscan, Aurélia Gruber, Hélène Lapillonne, Caroline Deswarte, P. Goussard, Ingrid Laurendeau,

Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematologyPathologyCell DeathTumor SuppressorTumour SuppressorLegius SyndromeMedicineCancer ResearchTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1